These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6144767)

  • 1. Controlled release of radioprotective agents from matrix tablets--effect of preparative conditions on release rates.
    Benita S; Shani J; Abdulrazik M; Samuni A
    J Pharm Pharmacol; 1984 Apr; 36(4):222-8. PubMed ID: 6144767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sustained-release radioprotective drugs in vivo.
    Shani J; Benita S; Abdulrazik M; Yerushalmi A
    Z Naturforsch C J Biosci; 1987; 42(11-12):1323-7. PubMed ID: 2966504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
    Quinten T; Gonnissen Y; Adriaens E; De Beer T; Cnudde V; Masschaele B; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Sci; 2009 Jun; 37(3-4):207-16. PubMed ID: 19491007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation for slow release of oral radiation-protection drugs.
    Abdulrazik M; Shani J; Benita S; Samuni A; Donbrow M; Yerushalmi A
    Int J Nucl Med Biol; 1984; 11(1):53-4. PubMed ID: 6610665
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose.
    Caviglioli G; Baldassari S; Cirrincione P; Russo E; Parodi B; Gatti P; Drava G
    Int J Pharm; 2013 Dec; 458(1):74-82. PubMed ID: 24144954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release.
    Agrawal AM; Neau SH; Bonate PL
    AAPS PharmSci; 2003; 5(2):E13. PubMed ID: 12866940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
    Ravi PR; Ganga S; Saha RN
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the atomization time on the properties of ethylcellulose microcapsules of isoniazid prepared by a fluidized bed.
    Senjković R; Jalsenjak I
    J Microencapsul; 1984; 1(3):241-7. PubMed ID: 6336528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.
    Cifuentes C; Aguilar-de-Leyva A; Rajabi-Siahboomi AR; Caraballo I
    Acta Pharm; 2013 Mar; 63(1):115-29. PubMed ID: 23482317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
    Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Square root of time dependence of matrix formulations with low drug content.
    Fessi H; Marty JP; Puisieux F; Carstensen JT
    J Pharm Sci; 1982 Jul; 71(7):749-52. PubMed ID: 7120057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
    Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
    Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
    Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.